Tag: phase 3 trial

October 2, 2019

Soleno Therapeutics Announces Data from Second Planned Data Safety Monitoring Board Review

The outcome of the second meeting was based off data from more than 50 percent of enrolled and treated patients.
September 30, 2019

Acasti Pharma Releases Additional Phase 3 Milestones

The company said that almost 80 percent of the patients in the Phase 3 TRILOGY trial have completed randomization in...
September 19, 2019

Rafael Pharma Expands Phase 3 Trial into South Korea

The clinical trials will kick off with an investigator meeting held on Sept. 19 in Seoul. The study is also...
August 19, 2019

Nabriva Notches First FDA Nod for Pneumonia Treatment

The FDA's approval of Xenleta is the first of its kind in almost two decades and will treat community-acquired bacterial...
March 6, 2019

Zealand Pharma Doses First Patient in Phase 3 Trial with Dasiglucagon for Treatment of Congenital Hyperinsulinism

Zealand Pharma (NASDAQ:ZEAL) has announced the dosing of the first patient in the first Phase 3 trial to evaluate dasiglucagon...
January 22, 2019

Incyte Announces First Patient Treated in Phase 3 Clinical Trial

Incyte (Nasdaq:INCY) today announced that the first patient has been treated in GRAVITAS-309, a pivotal Phase 3 trial for the...
November 27, 2018

Eyenovia Launches Phase 3 Clinical Trial

The company has enrolled the first patient in the first of two Phase 3 trials for its MicroStat program for...